OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology

OriGene Technologies, Inc. announced today the acquisition of Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd (ZsBio).

Founded in the year 1993, ZsBio provides testing products (pathology) within their domestic Chinese market, such as oncology diagnostics.

OriGene had the following to say regarding today’s acquisition, “With its leadership position in the Chinese pathology testing market, ZsBio is the ideal partner for OriGene,” said Wei-Wu He, CEO of OriGene.  “ZsBio is already a leader in pathology products for cancer applications and has a wide range of market-leading diagnostics products used in hospitals and laboratories in China. In turn, OriGene brings to ZsBio innovative highly specific monoclonal antibodies and assays to complement and strengthen ZsBio’s portfolio of products.”

In a market that has experienced double-digit market growth annually, OriGene hopes the acquisition of ZsBio bolsters their bottom-line.

OriGene Technologies, Inc., is a biosciences company dedicated to develop gene centric innovative products and services to improve the quality of healthcare diagnostics and treatments while ZsBio has more than 25 years of pathology diagnostics experience in China.

Latest News

Royal Bank of Canada Raises UnitedHealth Group  Price Target to $308.00
Royal Bank of Canada Raises UnitedHealth Group Price Target to $308.00
$47.94 Million in Sales Expected for PROS Holdings, Inc.  This Quarter
$47.94 Million in Sales Expected for PROS Holdings, Inc. This Quarter
Centaure Hits 24 Hour Trading Volume of $135.00
Centaure Hits 24 Hour Trading Volume of $135.00
Sakura Bloom  Trading 20.2% Lower  Over Last Week
Sakura Bloom Trading 20.2% Lower Over Last Week
Unum Group  Receives Average Rating of “Hold” from Analysts
Unum Group Receives Average Rating of “Hold” from Analysts
Zacks: Brokerages Expect Provident Financial Services, Inc.  Will Post Quarterly Sales of $89.09 Million
Zacks: Brokerages Expect Provident Financial Services, Inc. Will Post Quarterly Sales of $89.09 Million


© 2006-2018 Ticker Report. Google+.